Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo-Reference-Cited by-同舟云学术

Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo

Published:2009-08 Issue:8 Volume:17 Page:1453-1464
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Milone Michael C.,Fish Jonathan D.,Carpenito Carmine,Carroll Richard G.,Binder Gwendolyn K.,Teachey David,Samanta Minu,Lakhal Mehdi,Gloss Brian,Danet-Desnoyers Gwenn,Campana Dario,Riley James L.,Grupp Stephan A.,June Carl H.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy;Deeks;Mol Ther,2002

2. A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer;Kershaw;Clin Cancer Res,2006

3. Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells;Till;Blood,2008

4. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma;Pule;Nat Med,2008

5. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways;Irving;Cell,1991

Cited by 971 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor T‐cell therapy for haematological malignancies: Insights from fundamental and translational research to bedside practice;British Journal of Haematology;2024-09-11

2. CAR-T: from bench to bedside;Oncohematology;2024-09-03

3. The peptide-based bispecific CAR T cells target EGFR and tumor stroma for effective cancer therapy;International Journal of Pharmaceutics;2024-09

4. Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies;Blood Reviews;2024-09

5. Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab;Antibodies;2024-08-30